These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33181305)

  • 21. Lack of association between fluoroquinolone and aortic aneurysm or dissection.
    Huh K; Kang M; Jung J
    Eur Heart J; 2023 Nov; 44(42):4476-4484. PubMed ID: 37724037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
    Gopalakrishnan C; Bykov K; Fischer MA; Connolly JG; Gagne JJ; Fralick M
    JAMA Intern Med; 2020 Dec; 180(12):1596-1605. PubMed ID: 32897307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population-Based Cohort Study.
    Chen YY; Yang SF; Yeh HW; Yeh YT; Huang JY; Tsao SL; Yeh CB
    J Am Heart Assoc; 2022 Mar; 11(6):e023267. PubMed ID: 35229623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm.
    Newton ER; Akerman AW; Strassle PD; Kibbe MR
    JAMA Surg; 2021 Mar; 156(3):264-272. PubMed ID: 33404647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.
    Sommet A; Bénévent J; Rousseau V; Chebane L; Douros A; Montastruc JL; Montastruc F
    J Gen Intern Med; 2019 Apr; 34(4):502-503. PubMed ID: 30565153
    [No Abstract]   [Full Text] [Related]  

  • 26. Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments.
    Miyata K; Izawa-Ishizawa Y; Tsujinaka K; Nishi H; Itokazu S; Miyata T; Kondo M; Yoshioka T; Niimura T; Aizawa F; Yagi K; Sato M; Hyodo M; Hamano H; Kawada K; Chuma M; Zamami Y; Tsuneyama K; Goda M; Ishizawa K
    Biomed Pharmacother; 2024 Oct; 179():117418. PubMed ID: 39265233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks associated with the use of fluoroquinolones.
    DeLaney MC
    Br J Hosp Med (Lond); 2018 Oct; 79(10):552-555. PubMed ID: 30290736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association Between Fluoroquinolone Use and the Outcome of Aortic Aneurysm or Dissection.
    Chen CH; Wang CY; Lai CC
    J Am Coll Cardiol; 2021 Aug; 78(6):638-639. PubMed ID: 34353543
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply: The Association Between Fluoroquinolone Use and the Outcome of Aortic Aneurysm or Dissection.
    Chen SW; Chan YH; Chien-Chia Wu V; Chu PH; Chou AH
    J Am Coll Cardiol; 2021 Aug; 78(6):639-641. PubMed ID: 34353544
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serious side effects of fluoroquinolones: low risk of connective tissue-related disorders such as aneurysms].
    Boes J; Dofferhoff ASM; Fleuren HWHA; Kramers C
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33332024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of aortic aneurysm and dissection following exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospective analyses of three large healthcare databases in the US.
    Londhe AA; Holy CE; Weaver J; Fonseca S; Villasis A; Fife D
    PLoS One; 2021; 16(8):e0255887. PubMed ID: 34398907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of fluoroquinolones use with the risk of aortic aneurysm or aortic dissection: Facts and myths.
    Lai CC; Lu CT; Kao KC; Lu MC; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2021 Apr; 54(2):182-184. PubMed ID: 33775552
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study.
    Pasternak B; Inghammar M; Svanström H
    BMJ; 2018 Mar; 360():k678. PubMed ID: 29519881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolones increase susceptibility to aortic aneurysm and aortic dissection: Molecular mechanism and clinical evidence.
    Xuan X; Li Y; Cao G; Zhang R; Hu J; Jin H; Dong H
    Vasc Med; 2023 Dec; 28(6):604-613. PubMed ID: 37756313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.
    Meng L; Huang J; Jia Y; Huang H; Qiu F; Sun S
    Int J Clin Pract; 2019 May; 73(5):e13331. PubMed ID: 30809871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Intracranial Aneurysm and Dissection and Fluoroquinolone Use: A Case-Time-Control Study.
    Maumus-Robert S; Debette S; Bérard X; Mansiaux Y; Tubert-Bitter P; Pariente A
    Stroke; 2020 Mar; 51(3):994-997. PubMed ID: 31964291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.
    Daneman N; Lu H; Redelmeier DA
    BMJ Open; 2015 Nov; 5(11):e010077. PubMed ID: 26582407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated.
    Tamargo J; Agewall S
    Eur Heart J; 2023 Nov; 44(42):4485-4487. PubMed ID: 37862581
    [No Abstract]   [Full Text] [Related]  

  • 39. [Not Available].
    Pulz S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):514-5. PubMed ID: 27631440
    [No Abstract]   [Full Text] [Related]  

  • 40. Does autosomal dominant polycystic kidney disease increase the risk of aortic aneurysm or dissection: a point of view based on a systematic review and meta-analysis.
    Nunes R; Gouveia E Melo R; Almeida AG; de Almeida E; Pinto FJ; Pedro LM; Caldeira D
    J Nephrol; 2022 Jul; 35(6):1585-1593. PubMed ID: 35347648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.